Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
SYNTHELIS logo — Cell-free systems expert ! The futures of protein ! Best ch...

SYNTHELIS

Cell-free systems expert ! The futures of protein ! Best chance for your protein projects !

Founded 2011 France France 10 employees Series Unknown Total: $610.00K Biotechnology, Health Care +2

General Information

Company Name SYNTHELIS
Founded Year 2011
Location France France +1
Employees 10
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Series Unknown
Social

Get notified when SYNTHELIS moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SYNTHELIS

SYNTHELIS is a French biotech company based in Grenoble, at the heart of the French Alps, pioneering in Cell-Free systems. Established in 2011, it has become a benchmark in Europe with its proprietary cell-free expression technology and is now positioned to compete with US leaders in the field. The company addresses the pressing need to efficiently produce diverse proteins in research and anticipates its growing significance in various industries in the future. The consistent growth in cell-free expression expertise aligns with the unfolding industrial revolution, and SYNTHELIS is dedicated to advancing its research to contribute to the emergence of synthetic biology. The company secured a €610.00K Venture Round investment on 21 January 2014 from Alpes Developpement Durable Investissement, Rhone-Alpes Creation, Sud Rhone-Alpes Capital, and Viadeo. With its strong expertise and strategic vision, SYNTHELIS presents a promising opportunity for venture capitalists in the dynamic biotech landscape.

Taxonomy: Cell-Free Systems, Protein Expression, Membrane Proteins, Proteoliposomes, Detergent Format, Pharmaceutical Services, Biotech, Vaccine Development, Screening Technologies, Antibody Development, In Vitro Diagnostics, Structural Biology, Protein Purification, Therapeutic Proteins, Synthetic Biology

Services & Products

Expression of Proteins in Cell-Free Systems
Expression of Proteins in E. coli
Bioluminescence Products and Services

Target Customers

Biopharmaceutical Industry Biotechnology Companies Diagnostic Laboratories Academic Research Institutions

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 4
Investor Investor Investor
•••• •••• 		21 Jan 2014

SYNTHELIS Alternatives & Competitors

SYNTHELIS vs
U-Protein Express BV
U-Protein Express BV The Netherlands

U-Protein Express BV was acquired by ImmunoPrecise Antibodies Ltd.. Visit www.ImmunoPrecise.com for...

8 employees
Biotechnology
SYNTHELIS vs
神州细胞工程有限公司
神州细胞工程有限公司

Pioneering accessible and affordable biological medicines through advanced protein and antibody tech...

Series A
91 employees
Biotechnology, Health Care
SYNTHELIS vs
Nuclera
Nuclera United Kingdom

Bring rapid protein access to your benchtop with eProtein Discovery

Series C
114 employees
Biotechnology, Life Sciences

FAQ About SYNTHELIS

Cell-free systems expert ! The futures of protein ! Best chance for your protein projects !
SYNTHELIS was founded in 2011.
SYNTHELIS is headquartered in France.
SYNTHELIS operates in the following industries: Biotechnology, Health Care, Manufacturing, Transportation.
SYNTHELIS has approximately 10 employees.
SYNTHELIS has completed 1 funding round, raising a total of $610.00K. The latest funding stage is Series Unknown.
SYNTHELIS offers: Expression of Proteins in Cell-Free Systems, Expression of Proteins in E. coli, Bioluminescence Products and Services.
Top alternatives and competitors to SYNTHELIS include U-Protein Express BV, 神州细胞工程有限公司, Nuclera, Retrogenix, MoleculeMind. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SYNTHELIS and U-Protein Express BV are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SYNTHELIS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy